4.7 Article

Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial

Matthew Van Oirschot et al.

Summary: This study assessed the association between target coverage compromise and patient outcomes in SABR treatment for oligometastases. The results showed that for some lesions, a reduction in dose or target coverage was necessary to meet organ at risk constraints. However, target coverage was not significantly associated with survival outcomes or lesional control.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Article Oncology

CT-guided versus MR-guided radiotherapy: Impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy

Lori L. Rodriguez et al.

Summary: The study compared the treatment efficacy between adaptive IMRT MRgRT(BH) and VMAT CT-IGRT(BH). The results showed that MRgRT(BH) was able to safely deliver ablative doses with real-time motion tracking, providing better target coverage and conformality. However, CT-IGRT(BH) demonstrated superior performance in terms of target coverage and gastrointestinal organ-at-risk doses.

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET) – Extended Long-Term Outcomes

Stephen Harrow et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Article Oncology

Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate

Lukas Nierer et al.

Summary: This study evaluated the dosimetric benefits of online adaptive MR-guided radiotherapy (oMRgRT) across different tumor entities and found significant improvements in target volume coverage and organ at risk (OAR) sparing. Different tumor subgroups showed varying degrees of improvement, with the liver, lung, and abdominal lymph nodes subgroups benefiting the most.

RADIATION ONCOLOGY (2022)

Article Oncology

Treatment patterns for adrenal metastases using surgery and SABR during a 10-year period

Claire van Vliet et al.

Summary: This study investigated treatment patterns for adrenal metastases using surgery or SABR at a single institution. The number of patients undergoing SABR doubled since 2016, while the numbers undergoing surgery remained unchanged. Both treatments showed low rates of acute toxicity and similar survival outcomes.

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study

Morgan Michalet et al.

Summary: This study investigated the dosimetric benefits and clinical outcomes of SMART treatment for pancreatic tumors. The results showed that daily adaptation of SMART improved tumor coverage and organ protection, with low toxicity and promising survival rates.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Impact of daily plan adaptation on organ-at-risk normal tissue complication probability for adrenal lesions undergoing stereotactic ablative radiation therapy

Hanbo Chen et al.

Summary: This study shows that MR-guided daily-adaptive SABR can reduce gastric toxicity in patients with left adrenal tumors, while dose escalation may be considered for patients with right-sided lesions due to low predicted NTCP. Adaptation benefits were significantly associated with lesion laterality, with left-sided lesions benefiting more than right-sided lesions.

RADIOTHERAPY AND ONCOLOGY (2021)

Article Oncology

Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients

William C. Chen et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Article Oncology

Changes in gastric anatomy after delivery of breath-hold MR-guided SABR for adrenal metastases

John R. van Sornsen de Koste et al.

RADIOTHERAPY AND ONCOLOGY (2020)

Article Oncology

Hybrid radiotherapy machines: Evolution or revolution?

L. Ferrer et al.

CANCER RADIOTHERAPIE (2019)

Review Oncology

Online Adaptive Radiation Therapy

Stephanie Lim-Reinders et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)

Article Oncology

Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications

Sahaja Acharya et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

Review Oncology

SBRT: A viable option for treating adrenal gland metastases

Edy Ippolito et al.

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2015)

Article Oncology

The ViewRay System: Magnetic Resonance-Guided and Controlled Radiotherapy

Sasa Mutic et al.

SEMINARS IN RADIATION ONCOLOGY (2014)

Article Oncology

Role of Radiotherapy for Local Control of Asymptomatic Adrenal Metastasis From Lung Cancer

Yoshiko Oshiro et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)

Article Endocrinology & Metabolism

Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital

KY Lam et al.

CLINICAL ENDOCRINOLOGY (2002)